Pay in 4 interest-free payments of $33.75 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Molecular Weight: 331
Metabolic labelling of choline phospholipids probes ABCA3 transport in lamellar bodies
safe and effective HIV-1 attachment inhibitor
A chemical switch for inhibitor-sensitive alleles of any protein kinase
Dipraglurant Catalog No.:M10339-2 Molecular Weight: 331Dipraglurant, aslo known as ADX 48621, is a negative allosteric modulator of the mGlu5 receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa induced dyskinesia (PD LID). Blocking metabotropic glutamate receptor type 5 (mGluR5) has been proposed as a target for levodopa induced dyskinesias (LID) in Parkinson's disease (PD). Acute challenges of dipraglurant were efficacious on choreic and dystonic
US$ 62.00
US$ 27.00
US$ 30.00
US$ 15.99
US$ 99.00
US$ 199.00